These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35290421)

  • 1. Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in eThekwini, South Africa, 2016-2020.
    Rao A; Mhlophe H; Comins C; Young K; Mcingana M; Lesko C; Mulumba N; Baral S; Hausler H; Schwartz S
    PLoS One; 2022; 17(3):e0265434. PubMed ID: 35290421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa.
    Rao A; Lesko C; Mhlophe H; Rucinski K; Mcingana M; Pretorius A; Mcloughlin J; Baral S; Beyrer C; Hausler H; Schwartz S
    AIDS; 2023 May; 37(6):977-986. PubMed ID: 36723509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of implementation strategies on pre-exposure prophylaxis persistence among female sex workers in South Africa: an interrupted time series study.
    Rao A; Mhlophe H; Pretorius A; Mcingana M; Mcloughlin J; Shipp L; Baral S; Hausler H; Schwartz S; Lesko C
    Lancet HIV; 2023 Dec; 10(12):e807-e815. PubMed ID: 38040479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.
    Stone J; Bothma R; Gomez GB; Eakle R; Mukandavire C; Subedar H; Fraser H; Boily MC; Schwartz S; Coetzee J; Otwombe K; Milovanovic M; Baral S; Johnson LF; Venter WDF; Rees H; Vickerman P
    J Int AIDS Soc; 2023 Feb; 26(2):e26063. PubMed ID: 36807874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda.
    Kagaayi J; Batte J; Nakawooya H; Kigozi B; Nakigozi G; Strömdahl S; Ekström AM; Chang LW; Gray R; Reynolds SJ; Komaketch P; Alamo S; Serwadda D
    J Int AIDS Soc; 2020 Aug; 23(8):e25588. PubMed ID: 32785976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "I am still negative": Female sex workers' perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa.
    Eakle R; Bothma R; Bourne A; Gumede S; Motsosi K; Rees H
    PLoS One; 2019; 14(4):e0212271. PubMed ID: 30964874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context.
    Tomko C; Park JN; Allen ST; Glick J; Galai N; Decker MR; Footer KHA; Sherman SG
    AIDS Patient Care STDS; 2019 Feb; 33(2):49-57. PubMed ID: 30632769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV pre-exposure prophylaxis uptake, retention and adherence among female sex workers in sub-Saharan Africa: a systematic review.
    Mpirirwe R; Segawa I; Ojiambo KO; Kamacooko O; Nangendo J; Semitala FC; Kyambadde P; Kalyango JN; Kiragga A; Karamagi C; Katahoire A; Kamya M; Mujugira A
    BMJ Open; 2024 Apr; 14(4):e076545. PubMed ID: 38670600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal.
    Sarr M; Gueye D; Mboup A; Diouf O; Bao MDB; Ndiaye AJ; Ndiaye BP; Hawes SE; Tousset E; Diallo A; Jones F; Kane CT; Thiam S; Ndour CT; Gottlieb GS; Mboup S
    Int J STD AIDS; 2020 Oct; 31(11):1063-1072. PubMed ID: 32819210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and willingness of HIV pre-exposure prophylaxis amongst female sex workers in China.
    Poon AN; Han L; Li Z; Zhou C; Li Y; Huang L; Liao M; Shepard C; Bulterys M
    AIDS Care; 2019 Dec; 31(12):1555-1564. PubMed ID: 31046413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of HIV oral pre-exposure prophylaxis: findings from programmatic surveillance within two general population HIV programs in Nigeria.
    Anyasi H; Idemudia A; Badru T; Onyegbule S; Isang E; Sanwo O; Pandey SR; Chiegil R; Bateganya M; Schwartz K; Njuguna N; Persaud N; Plotkin M; Iyortim I; Khamofu H
    BMC Public Health; 2024 May; 24(1):1325. PubMed ID: 38755630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S.
    Pelaez D; Weicker NP; Glick J; Mesenburg JV; Wilson A; Kirkpatrick H; Clouse E; Sherman SG
    AIDS Care; 2021; 33(sup1):1-10. PubMed ID: 33627006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.
    Dunbar MS; Kripke K; Haberer J; Castor D; Dalal S; Mukoma W; Mullick S; Patel P; Reed J; Subedar H; Were D; Warren M; Torjesen K
    Sex Health; 2018 Nov; 15(6):513-521. PubMed ID: 30408431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.
    Coy KC; Hazen RJ; Kirkham HS; Delpino A; Siegler AJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25252. PubMed ID: 30775846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.
    Footer KHA; Lim S; Rael CT; Greene GJ; Carballa-Diéguez A; Giguere R; Martinez M; Bockting W; D'Aquila R; Sherman SG
    AIDS Care; 2019 Oct; 31(10):1207-1213. PubMed ID: 30822101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.